Article
Biochemistry & Molecular Biology
Saad Fettach, Fatima Zahra Thari, Zakaria Hafidi, Khalid Karrouchi, Kaoutar Bouathmany, Yahia Cherrah, Mohammed El Achouri, Laila Benbacer, Mohammed El Mzibri, Hassan Sefrioui, Khalid Bougrin, My El Abbes Faouzi
Summary: In this study, three new isoxazoline-thiazolidine-2,4-dione derivatives were synthesized and assessed for their inhibitory activities against alpha-amylase and alpha-glucosidase. The compounds exhibited potent inhibitory effects on both enzymes and showed no cytotoxicity in in vitro and in vivo evaluations. Computational analysis confirmed the molecular binding properties of the compounds with the active sites of the enzymes. These findings highlight the potential of the synthesized derivatives in controlling hyperglycemia and type 2 diabetes mellitus without causing hepatic toxicity.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
(2023)
Article
Chemistry, Medicinal
Maria Stefania Sinicropi, Jessica Ceramella, Patrice Vanelle, Domenico Iacopetta, Camillo Rosano, Omar Khoumeri, Shawkat Abdelmohsen, Wafaa Abdelhady, Hussein El-Kashef
Summary: Cancer is a complex disease and developing new compounds for cancer treatments is urgently needed. In recent years, the design and synthesis of innovative hybrid molecules have gained interest, with promising results in inhibiting cancer cells. The tested hybrid compounds containing trimethoxybenzene, thiazolidinedione and thiazole showed good efficacy against breast cancer cells, with compound 7e being the most effective. Docking simulations indicated that these compounds may target human Topoisomerases I and II, and enzymatic assays confirmed their inhibitory activity. Compound 7e was found to induce apoptosis in MCF-7 cells. These findings support further research in designing and synthesizing analogues for anticancer purposes.
Article
Chemistry, Multidisciplinary
Hazem Elkady, Osama A. El-Dardir, Alaa Elwan, Mohammed S. Taghour, Hazem A. Mahdy, Mohammed A. Dahab, Eslam B. Elkaeed, Bshra A. Alsfouk, Ibrahim M. Ibrahim, Dalal Z. Husein, Elsayed E. Hafez, Amira M. G. Darwish, Ahmed M. Metwaly, Ibrahim H. Eissa
Summary: In this study, novel VEGFR-2-targeting thiazolidine-2,4-dione derivatives were designed and synthesized. The compounds demonstrated potent anti-VEGFR-2 activity and inhibited the growth of three different cancer cell types. Compound 15 showed the best anti-VEGFR-2 potency and exhibited remarkable anti-proliferative activities against the tested cancer cell lines. Computational methods were used to analyze the molecular characteristics of the VEGFR-2-15 complex, and ADMET and toxicity experiments were conducted to evaluate the therapeutic potential of the synthesized compounds. The findings suggest that compound 15 may serve as an effective anticancer lead compound.
Review
Medicine, Research & Experimental
Srinivasa R. Vulichi, Atul Kabra, Rupak Kumar, Kapur Suman, Chunduri Venkata Rao, Natalia Cruz-Martins
Summary: Glitazones are synthetic derivatives of thiazolidinedione that primarily act on peroxisome proliferator-activated receptor-gamma (PPAR-y) receptors to regulate metabolic pathways linked to glucose and lipid metabolism at a transcriptional level. Despite their high efficacy and selectivity in clinical settings, glitazones are restricted for long-term usage due to potential adverse effects such as weight gain and heart-related complications.
Article
Biochemistry & Molecular Biology
Musherah M. Alshammari, Raoudha Soury, Khalaf M. Alenezi, Md. Mushtque, M. Moshahid Alam Rizvi, Ashanul Haque
Summary: A new pyrazole-tethered thiazolidine-2,4-dione derivative was synthesized and its structure was confirmed by spectroscopic techniques. Density functional theory calculations were used to determine the molecular features. In vitro cytotoxicity studies showed higher activity and lower toxicity of the compound against breast cancer cell line.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
(2022)
Article
Chemistry, Physical
Tatyana V. Volkova, Olga R. Simonova, German L. Perlovich
Summary: This study investigates the physicochemical properties of the novel potential antifungal compound TZD in the presence of 2HP-beta-CD, focusing on solubility, distribution, and membrane permeability. The experiments were carried out at different temperatures and pH values to predict the behavior of TZD in biological media. The results provide insights into the role of hydrogen bonding and the permeation of TZD across stomach and intestine membranes.
JOURNAL OF MOLECULAR LIQUIDS
(2021)
Article
Biochemistry & Molecular Biology
Musherah M. Alshammari, Raoudha Soury, Khalaf M. Alenezi, Md Mushtque, M. Moshahid Alam Rizvi, Ashanul Haque
Summary: A new pyrazole-tethered thiazolidine-2,4-dione derivative was synthesized and displayed higher activity and lower toxicity towards breast cancer cell line compared to its intermediate compound. The study also involved spectroscopic confirmation, theoretical calculations, in vitro cytotoxicity testing, and complementary docking and ADME studies.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
(2021)
Article
Chemistry, Physical
Svetlana Blokhina, Angelica Sharapova, Marina Ol'khovich, Igor B. Levshin, German L. Perlovich
Summary: The novel antimicrobial agent (5Z)-3-(3-(4-acetylpiperazin-1-yl)-2-hydroxypropyl)-5-(4-chlorobenzylidene)thiazolidine-2,4-dione was synthesized, and its solubility was found to increase with temperature. The distribution process of the compound in two-phase systems was described as thermodynamically favorable, endothermic, and entropy-driven.
JOURNAL OF MOLECULAR LIQUIDS
(2021)
Article
Chemistry, Multidisciplinary
Bushra Ansari, Haroon Khan, Muhammad Saeed Jan, Khalaf F. Alsharif, Khalid J. Alzahrani, Umer Rashid, Abdul Saboor Pirzada
Summary: Various derivatives of thiazolidine-2,4-dione (C1-C5) were synthesized through chemical reaction and modification, and their chemical structures were determined by NMR spectroscopy. In silico ADME studies revealed the pharmacokinetic properties of the compounds, including rotatable bonds, lipophilicity, water solubility, GI absorption, blood-brain barrier permeability, and drug metabolism. The study also evaluated the drug likeness properties of the derivatives. The results suggest that these compounds have potential for improving pharmacokinetic profiles and reducing toxicity.
JOURNAL OF CHEMISTRY
(2023)
Article
Chemistry, Multidisciplinary
Yingying Zheng, Mengyu Li, Simin Wu, Lu Li, Zhuang Xiong, Xuetao Xu, Kun Zhang, Yi Wen
Summary: A series of chromone-thiazolidine-2,4-dione derivatives were synthesized and tested for their a-glucosidase inhibitory activity. Compound e28 showed the strongest inhibitory activity, which was reversible and non-competitive. Further studies revealed that e28 had good safety.
ARABIAN JOURNAL OF CHEMISTRY
(2023)
Article
Chemistry, Physical
Gabriel Marc, Anca Stana, Adrian Pirnau, Laurian Vlase, Smaranda Oniga, Ovidiu Oniga
Summary: The study discusses the importance of thiazolidine-2,4-dione in medicinal chemistry and the synthesis of its derivatives through N-alkylation and O-alkylation reactions. Experimental results indicate the formation of N-alkylated derivatives under reaction conditions, providing a new pathway for the synthesis of biologically active compounds.
JOURNAL OF MOLECULAR STRUCTURE
(2021)
Article
Biochemistry & Molecular Biology
Li Lu, Chunmei Hu, Xiaofeng Min, Zhong Liu, Xuetao Xu, Lishe Gan
Summary: A new tyrosinase inhibitor with anti-melanogenic activity was discovered through the synthesis of a series of derivatives. The compound showed inhibitory activity against tyrosinase and could suppress melanogenesis both in cells and in a zebrafish model.
Article
Biochemistry & Molecular Biology
Bo Jiang, Jiao Luo, Shuju Guo, Lijun Wang
Summary: In this study, molecules containing 2,4-thiazolidinedione and hydantoin were designed, synthesized and evaluated for PTP1B inhibitory potency. Compound 5a was identified as a potent PTP1B inhibitor with selectivity over TCPTP, leading to improvements in blood glucose levels, insulin sensitivity, liver glycogen storage, and pancreatic islet structure in diabetic mice. These results suggest that compound 5a could be a promising lead compound for new antidiabetic drug discovery.
BIOORGANIC CHEMISTRY
(2021)
Article
Education, Scientific Disciplines
Dolly R. Pardeshi, Vithal M. Kulkarni, Sandeep S. Pathare
Summary: This study focuses on the synthesis and screening of new analogues of thiazolidine-2,4-dione (TZD) as potential antidiabetic agents. The results showed that three synthesized compounds exhibited significant antidiabetic activity in diabetic mice, comparable to Pioglitazone drug. These compounds did not show any toxic effects in mice, highlighting the importance of synthesizing and improving thiazolidine-2,4-dione-containing drugs in antidiabetic drug research.
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH
(2023)
Article
Engineering, Chemical
Mahmoud A. Shouman, Ahmed H. El-Shazly, Marwa F. Elkady, Mohamed Nabil Sabry, Ramma Kamogawa, Koki Nonaka, Mitsuru Sasaki, Akimaro Kawahara
Summary: Microreactor technology is considered a breakthrough technology for industries and research fields. The study showed that using a microtube reactor system can produce drug intermediates more efficiently compared to batch reactor systems.
CHEMICAL ENGINEERING SCIENCE
(2022)